Business Segments · Operating Income (Loss)
Analytical Instruments — Operating Income (Loss)
Thermo Fisher Scientific Analytical Instruments — Operating Income (Loss) decreased by 80.9% to $355M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 79.3%, from $1.72B to $355M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Rolls up toOperating Income
How to read this metric
An increase indicates improved operational efficiency or higher sales volume, while a decrease indicates margin pressure or rising costs.
Detailed definition
The profit or loss generated by the Analytical Instruments segment after deducting all operating expenses from total rev...
Peer comparison
The primary benchmark for comparing the operational performance of business segments across the industry.
Metric ID:
tmo_segment_analytical_instruments_operating_income_lossHistorical Data
37 periods
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.16B | $280M | $2.28B | $264M | $2.54B | $381M | $2.82B | $301M | $2B | $344M | $1.71B | $386M | $1.86B | $476M | $1.56B | $421M | $1.58B | $432M | $1.86B | $468M | $1.85B | $587M | $1.66B | $400M | $1.82B | $439M | $1.84B | $451M | $2.02B | $666M | $1.72B | $399M | $325M | $429M | $583M | $1.86B | $355M |
| QoQ Change | — | -87.1% | +713.6% | -88.4% | +861.4% | -85.0% | +640.4% | -89.3% | +564.8% | -82.8% | +397.1% | -77.4% | +382.1% | -74.4% | +228.4% | -73.1% | +274.8% | -72.6% | +331.5% | -74.9% | +296.2% | -68.3% | +183.3% | -75.9% | +355.0% | -75.9% | +318.7% | -75.5% | +347.0% | -67.0% | +157.7% | -76.7% | -18.5% | +32.0% | +35.9% | +219.6% | -80.9% |
| YoY Change | — | — | — | — | — | — | — | — | -7.5% | -84.1% | -24.9% | -83.1% | -26.7% | -81.2% | -44.6% | -85.1% | -21.1% | -78.4% | +9.0% | -72.6% | -0.4% | -68.5% | +6.4% | -74.4% | +15.3% | -72.2% | -1.4% | -75.8% | +8.7% | -64.1% | +3.2% | -76.0% | -82.1% | -76.7% | -71.1% | +8.6% | -79.3% |
Range$264M – $2.82B
CAGR-18.2%
Avg YoY Growth-44.8%
Median YoY Growth-68.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's analytical instruments — operating income (loss)?
- Thermo Fisher Scientific (TMO) reported analytical instruments — operating income (loss) of $355M in Q1 2026.
- How has Thermo Fisher Scientific's analytical instruments — operating income (loss) changed year-over-year?
- Thermo Fisher Scientific's analytical instruments — operating income (loss) decreased by 79.3% year-over-year, from $1.72B to $355M.
- What does analytical instruments — operating income (loss) mean?
- The core profit earned by the segment from its daily operations.